Cargando…

Hydroxychloroquine for prophylaxis of COVID-19 in health workers: A randomized clinical trial

INTRODUCTION: Health care workers are at high risk of being infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Our aim is to evaluate the efficacy and safety of hydroxychloroquine (HCQ) for prophylaxis of coronavirus disease 19 (COVID-19) in health personnel exposed to p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rojas-Serrano, Jorge, Portillo-Vásquez, Angelica Margarita, Thirion-Romero, Ireri, Vázquez-Pérez, Joel, Mejía-Nepomuceno, Fidencio, Ramírez-Venegas, Alejandra, Pérez-Kawabe, Karla Midori, Pérez-Padilla, Rogelio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827445/ https://www.ncbi.nlm.nih.gov/pubmed/35139097 http://dx.doi.org/10.1371/journal.pone.0261980

Ejemplares similares

Avoidance of hypoxemia in COPD is essential
por: Rodríguez-Llamazares, Sebastián, et al.
Publicado: (2020)

Hydroxychloroquine for the treatment of severe respiratory infection by COVID-19: A randomized controlled trial
por: Hernandez-Cardenas, Carmen, et al.
Publicado: (2021)

Longitudinal Characterization of a Neutralizing and Total Antibody Response in Patients with Severe COVID-19 and Fatal Outcomes
por: Serna-Muñoz, Ricardo, et al.
Publicado: (2022)

Clinical Markers of Chronic Hypoxemia in Respiratory Patients Residing at Moderate Altitude
por: Fernández-Plata, Rosario, et al.
Publicado: (2021)

Air quality in Mexico City during the COVID-19 lockdown possibly decreased COPD exacerbations
por: Montiel-Lopez, Francisco, et al.
Publicado: (2022)

Microbiota composition in the lower respiratory tract is associated with severity in patients with acute respiratory distress by influenza
por: Hernández-Terán, Alejandra, et al.
Publicado: (2023)

Trajectories of Spirometric Patterns, Obstructive and PRISm, in a Population-Based Cohort in Latin America
por: Perez-Padilla, Rogelio, et al.
Publicado: (2023)

Macrophage Exposure to Polycyclic Aromatic Hydrocarbons From Wood Smoke Reduces the Ability to Control Growth of Mycobacterium tuberculosis
por: Sada-Ovalle, Isabel, et al.
Publicado: (2018)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
por: Ambrocio-Ortiz, Enrique, et al.
Publicado: (2021)

Dysbiosis and structural disruption of the respiratory microbiota in COVID-19 patients with severe and fatal outcomes
por: Hernández-Terán, Alejandra, et al.
Publicado: (2021)

Risks of hydroxychloroquine use for COVID-19 prophylaxis
por: Sachdeva, Muskaan, et al.
Publicado: (2020)

Hydroxychloroquine prophylaxis for COVID-19 contacts in India
por: Rathi, Sahaj, et al.
Publicado: (2020)

Hydroxychloroquine as Prophylaxis for COVID-19: A Review
por: Monti, Manuela, et al.
Publicado: (2020)

Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trials
por: Hong, Hwanhee, et al.
Publicado: (2023)

Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models
por: Rosenke, Kyle, et al.
Publicado: (2020)

COVID-19: Hydroxychloroquine prophylaxis is just a prophylaxis! Be careful and perceive it right
por: Garg, Rakesh, et al.
Publicado: (2022)

Clinical and Virological Features of Patients Hospitalized with Different Types of COVID-19 Vaccination in Mexico City
por: Hernández-Terán, Alejandra, et al.
Publicado: (2022)

Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection
por: Carafoli, Ernesto
Publicado: (2021)

Response to: “Risks of hydroxychloroquine use for COVID-19 prophylaxis”
por: Grant-Kels, Jane M.
Publicado: (2020)

Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis
por: Faruqui, Atiya R., et al.
Publicado: (2021)

Lung Microbiome Participation in Local Immune Response Regulation in Respiratory Diseases
por: Lira-Lucio, Juan Alberto, et al.
Publicado: (2020)

Effect of Personal Exposure to PM(2.5) on Respiratory Health in a Mexican Panel of Patients with COPD
por: Cortez-Lugo, Marlene, et al.
Publicado: (2015)

Evaluation of Panbio rapid antigen test for SARS‐CoV‐2 in symptomatic patients and their contacts: a multicenter study
por: Thirion-Romero, Ireri, et al.
Publicado: (2021)

Intereses del niño de tres años de edad dentro de la guardería infantil 001 del Instituto Mexicano del Seguro Social en la Cd. de Poza Rica de Hgo., Ver. /
por: Pérez Ramírez, Ireri
Publicado: (1994)

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
por: Boulware, David R., et al.
Publicado: (2020)

Hydroxychloroquine for prophylaxis and treatment of COVID-19 in health-care workers
por: Simova, I., et al.
Publicado: (2020)

Potentials of Interferons and Hydroxychloroquine for the Prophylaxis and Early Treatment of COVID-19
por: Yang, Alexander, et al.
Publicado: (2020)

Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen
por: Pareek, Anil, et al.
Publicado: (2020)

Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19: What Is Known?
por: Shankar, Pathiyil Ravi, et al.
Publicado: (2021)

Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19
por: Kulkarni, Chanda, et al.
Publicado: (2021)

Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials
por: Galvis, Virgilio, et al.
Publicado: (2020)

Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials
por: Galvis, Virgilio, et al.
Publicado: (2020)

Use of hydroxychloroquine and interferon alpha-2b for the prophylaxis of COVID-19
por: Yang, Alexander, et al.
Publicado: (2020)

Interpreting the impact of hydroxychloroquine prophylaxis on SARS-CoV-2 infection
por: Yadav, Reetika Malik, et al.
Publicado: (2021)

Side effects of hydroxychloroquine prophylaxis against COVID-19 in healthcare workers
por: Dixit, Prashant Kumar, et al.
Publicado: (2021)

Hydroxychloroquine for the treatment and prophylaxis of COVID-19: The journey so far and the road ahead
por: Singh, Harmanjit, et al.
Publicado: (2021)

Hydroxychloroquine as antiviral prophylaxis for exposed caregivers to Covid-19: An urgent appraisal is needed()
por: Tahiri Joutei Hassani, Rachid, et al.
Publicado: (2020)

Hydroxychloroquine in the prophylaxis of COVID 19: A survey of safety on the healthcare workers in India
por: Mukhopadhyay, Sandip, et al.
Publicado: (2021)

Hydroxychloroquine prophylaxis for SARS-CoV-2 infection among healthcare workers
por: Karim, Habib M.R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l2be6aupolhkam04llu543vk6j